Paredrine

Active Ingredient(s): Hydroxyamphetamine
FDA Approved: * July 16, 1969
Pharm Company: * AKORN
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Paredrine Overview

4-Hydroxyamphetamine (4HA), also known as hydroxyamfetamine, hydroxyamphetamine, oxamphetamine, norpholedrine, para-hydroxyamphetamine, and α-methyltyramine, is a drug that stimulates the sympathetic nervous system. It is used medically in eye drops to dilate the pupil (a process called mydriasis), so that the back of the eye can be examined. It is also a major metabolite of amphetamine and certain substituted amphetamines. Contents 1 Medical use 2 Pharmacology 3 Commercialization 4...

Read more Paredrine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Hydroxyamfetamine

Recent Paredrine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Hydroxyamphetamine or a similar ingredient: (3 results)

• HYDROXYAMPHETAMINE
• HYDROXYAMPHETAMINE + TROPICAMIDE
• PAREMYD Hydroxyamphetamine + Tropicamide